Haemonetics Corporation
HAE · FY2026 · Fiscal year ended Mar 28, 2026 · 10-K filed May 2026
Open the dashboardInfographicSummary
FY2026 key figures
| $ | FY2026 | FY2025 | Change |
|---|---|---|---|
| Revenue | $1.33B | $1.36B | −2.0% |
| Operating income | $157M | $222M | −29.3% |
| Net income | $97.3M | $168M | −42.0% |
Latest quarter: Q2 FY2027
Form 10-Q · Three months ended Sep 26, 2026 · filed Nov 5, 2026
| $ | Q2 FY2027 | Year earlier | Change |
|---|---|---|---|
| Revenue | $358M | $327M | +9.3% |
| Operating income | $75.1M | $58.5M | +28.4% |
| Net income | $46.3M | $38.7M | +19.6% |
Q2 FY2027 dashboardQ2 FY2027 infographic
Questions
- What was Haemonetics's revenue in FY2026?
- $1.33B in FY2026 (Fiscal year ended Mar 28, 2026), −2.0% vs $1.36B a year earlier, per its 10-K filed May 2026.
- Was Haemonetics profitable in FY2026?
- Yes: net income was $97.3M and operating income $157M in FY2026.
- What was Haemonetics's revenue in Q2 FY2027?
- $358M (+9.3% vs a year earlier), per its Form 10-Q filed Nov 5, 2026.